T1	CHEM 13 24	misoprostol
#1	AnnotatorNotes T1	C0085174; misoprostol; Organic Chemical · Pharmacologic Substance
T2	PROC 592 617	randómicamente designadas
#2	AnnotatorNotes T2	C0034656; Randomization; Research Activity
T3	ANAT 61 68	uterino
#3	AnnotatorNotes T3	C0042149; Uterus; Body Part, Organ, or Organ Component | C1269032; Entire uterus; Body Part, Organ, or Organ Component
T4	PROC 80 89	anestesia
#4	AnnotatorNotes T4	C0002903; Anesthesia procedures; Therapeutic or Preventive Procedure
T5	CHEM 94 104	isoflurano
#5	AnnotatorNotes T5	C0022180; isoflurane; Organic Chemical · Pharmacologic Substance
T6	PROC 110 117	cesárea
#6	AnnotatorNotes T6	C0007876; Cesarean section; Therapeutic or Preventive Procedure
T7	CHEM 149 160	Misoprostol
#7	AnnotatorNotes T7	C0085174; misoprostol; Organic Chemical · Pharmacologic Substance
T8	DISO 226 247	efectos perjudiciales
#8	AnnotatorNotes T8	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T9	DISO 171 191	sangramiento uterino
#9	AnnotatorNotes T9	C0042134; Uterine hemorrhage; Pathologic Function
T10	DISO 204 221	parto por cesárea
#10	AnnotatorNotes T10	C1384674; Cesarean section (finding); Finding
T11	ANAT 1642 1660	gastrointestinales
#11	AnnotatorNotes T11	C0012240; Gastrointestinal system; Body System
T12	CHEM 318 329	misoprostol
#12	AnnotatorNotes T12	C0085174; misoprostol; Organic Chemical · Pharmacologic Substance
T14	ANAT 384 391	uterino
#13	AnnotatorNotes T14	C0042149; Uterus; Body Part, Organ, or Organ Component | C1269032; Entire uterus; Body Part, Organ, or Organ Component
T15	CHEM 411 420	ocitocina
#14	AnnotatorNotes T15	C0030095; oxytocin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T16	PROC 435 442	cesárea
#15	AnnotatorNotes T16	C0007876; Cesarean section; Therapeutic or Preventive Procedure
T17	PROC 448 457	anestesia
#16	AnnotatorNotes T17	C0002903; Anesthesia procedures; Therapeutic or Preventive Procedure
T18	CHEM 462 472	isoflurano
#17	AnnotatorNotes T18	C0022180; isoflurane; Organic Chemical · Pharmacologic Substance
T19	PROC 567 574	cesárea
#18	AnnotatorNotes T19	C0007876; Cesarean section; Therapeutic or Preventive Procedure
T20	CHEM 641 652	misoprostol
#19	AnnotatorNotes T20	C0085174; misoprostol; Organic Chemical · Pharmacologic Substance
T21	PROC 693 700	placebo
#20	AnnotatorNotes T21	C0032042; Placebos; Therapeutic or Preventive Procedure
T22	PROC 1051 1068	puntajes de Apgar
#21	AnnotatorNotes T22	C2825532; Apgar Test; Diagnostic Procedure
T23	PROC 725 735	intubación
#22	AnnotatorNotes T23	C0021925; Intubation (procedure); Therapeutic or Preventive Procedure
T24	PROC 740 749	anestesia
#23	AnnotatorNotes T24	C0002903; Anesthesia procedures; Therapeutic or Preventive Procedure
T25	CHEM 772 782	isoflurano
#24	AnnotatorNotes T25	C0022180; isoflurane; Organic Chemical · Pharmacologic Substance
T26	CHEM 795 808	óxido nitroso
#25	AnnotatorNotes T26	C0028215; nitrous oxide; Biologically Active Substance · Pharmacologic Substance · Inorganic Chemical
T27	CHEM 857 866	ocitocina
#26	AnnotatorNotes T27	C0030095; oxytocin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T28	DISO 935 952	pérdida sanguínea
#27	AnnotatorNotes T28	C0019080; Hemorrhage; Pathologic Function
T29	DISO 1248 1265	pérdida sanguínea
#28	AnnotatorNotes T29	C0019080; Hemorrhage; Pathologic Function
T30	ANAT 943 952	sanguínea
#29	AnnotatorNotes T30	C0005767; Blood; Body Substance
T31	ANAT 963 970	uterino
#30	AnnotatorNotes T31	C0042149; Uterus; Body Part, Organ, or Organ Component | C1269032; Entire uterus; Body Part, Organ, or Organ Component
T32	CHEM 991 1000	ocitocina
#31	AnnotatorNotes T32	C0030095; oxytocin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T33	PROC 1031 1042	hematocrito
#32	AnnotatorNotes T33	C0018935; Hematocrit procedure; Laboratory Procedure
T34	DISO 1102 1118	efectos adversos
#33	AnnotatorNotes T34	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T35	CHEM 1212 1223	misoprostol
#34	AnnotatorNotes T35	C0085174; misoprostol; Organic Chemical · Pharmacologic Substance
T36	ANAT 1256 1265	sanguínea
#35	AnnotatorNotes T36	C0005767; Blood; Body Substance
T37	CHEM 1338 1347	ocitocina
#36	AnnotatorNotes T37	C0030095; oxytocin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T38	PROC 1385 1396	hematocrito
#37	AnnotatorNotes T38	C0018935; Hematocrit procedure; Laboratory Procedure
T39	DISO 1473 1482	temblores
#38	AnnotatorNotes T39	C0040822; Tremor; Sign or Symptom | C0234369; Trembling; Sign or Symptom
T40	CHEM 1505 1516	misoprostol
#39	AnnotatorNotes T40	C0085174; misoprostol; Organic Chemical · Pharmacologic Substance
T41	DISO 1614 1629	náusea y vómito
#40	AnnotatorNotes T41	C0027498; Nausea and vomiting; Sign or Symptom
T42	DISO 1631 1660	trastornos gastrointestinales
#41	AnnotatorNotes T42	C0017178; Gastrointestinal Diseases; Disease or Syndrome
T43	DISO 1663 1669	fiebre
#42	AnnotatorNotes T43	C0015967; Fever; Sign or Symptom
T44	DISO 1788 1800	sangramiento
#43	AnnotatorNotes T44	C0019080; Hemorrhage; Pathologic Function
T45	ANAT 1832 1839	uterino
#44	AnnotatorNotes T45	C0042149; Uterus; Body Part, Organ, or Organ Component | C1269032; Entire uterus; Body Part, Organ, or Organ Component
T46	PROC 1846 1855	anestesia
#45	AnnotatorNotes T46	C0002903; Anesthesia procedures; Therapeutic or Preventive Procedure
T47	CHEM 1860 1870	isoflurano
#46	AnnotatorNotes T47	C0022180; isoflurane; Organic Chemical · Pharmacologic Substance
T48	DISO 1877 1894	parto por cesárea
#47	AnnotatorNotes T48	C1384674; Cesarean section (finding); Finding
T49	PROC 1596 1612	índices de Apgar
#48	AnnotatorNotes T49	C2825532; Apgar Test; Diagnostic Procedure
T50	ANAT 184 191	uterino
#49	AnnotatorNotes T50	C0042149; Uterus; Body Part, Organ, or Organ Component | C1269032; Entire uterus; Body Part, Organ, or Organ Component
T51	PROC 214 221	cesárea
#50	AnnotatorNotes T51	C0007876; Cesarean section; Therapeutic or Preventive Procedure
T52	PROC 845 853	infusión
#51	AnnotatorNotes T52	C0574032; Infusion procedures; Therapeutic or Preventive Procedure
T53	ANAT 905 913	placenta
#52	AnnotatorNotes T53	C0032043; Placenta; Embryonic Structure | C1278988; Entire placenta; Embryonic Structure
T54	PROC 1172 1181	inducción
#53	AnnotatorNotes T54	C0857127; Induction procedure; Therapeutic or Preventive Procedure
T55	PROC 1689 1703	administración
#54	AnnotatorNotes T55	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T56	CHEM 1721 1732	misoprostol
#55	AnnotatorNotes T56	C0085174; misoprostol; Organic Chemical · Pharmacologic Substance
T57	PROC 1887 1894	cesárea
#56	AnnotatorNotes T57	C0007876; Cesarean section; Therapeutic or Preventive Procedure
T58	Route 25 35	sublingual
#57	AnnotatorNotes T58	C0001565; Sublingual Route of Drug Administration; Functional Concept
T59	Time 36 49	preoperatorio
#58	AnnotatorNotes T59	C0445204; Preoperative; Temporal Concept | C2712277; Preoperative Period; Temporal Concept
T60	PHYS 56 68	tono uterino
T61	Neg_cue 222 225	sin
T62	LIVB 256 261	madre
#59	AnnotatorNotes T62	C0026591; Mother (person); Family Group
T63	LIVB 267 271	bebé
#60	AnnotatorNotes T63	C0021289; Infant, Newborn; Age Group
T64	Time 330 343	preoperatorio
#61	AnnotatorNotes T64	C0445204; Preoperative; Temporal Concept | C2712277; Preoperative Period; Temporal Concept
T66	PHYS 379 391	tono uterino
T67	LIVB 537 546	pacientes
#62	AnnotatorNotes T67	C0030705; Patients; Patient or Disabled Group
T68	Dose 631 637	400 µg
T69	Route 653 663	sublingual
#63	AnnotatorNotes T69	C0001565; Sublingual Route of Drug Administration; Functional Concept
T70	Dose 676 689	un comprimido
T71	LIVB 820 829	pacientes
#64	AnnotatorNotes T71	C0030705; Patients; Patient or Disabled Group
T73	Dose 868 873	10 UI
T74	PHYS 958 970	tono uterino
T76	Duration 1072 1095	el 1º y a los 5 minutos
T77	LIVB 1187 1196	pacientes
#65	AnnotatorNotes T77	C0030705; Patients; Patient or Disabled Group
T78	Route 1224 1234	sublingual
#66	AnnotatorNotes T78	C0001565; Sublingual Route of Drug Administration; Functional Concept
T79	Time 1266 1280	perioperatoria
#67	AnnotatorNotes T79	C1518988; perioperative; Temporal Concept | C2712230; Perioperative Period; Temporal Concept
T83	Time 1704 1717	preoperatoria
#68	AnnotatorNotes T83	C0445204; Preoperative; Temporal Concept | C2712277; Preoperative Period; Temporal Concept
T84	Route 1733 1743	sublingual
#69	AnnotatorNotes T84	C0001565; Sublingual Route of Drug Administration; Functional Concept
T85	Dose 1745 1751	400 µg
T87	PHYS 1827 1839	tono uterino
T88	PHYS 204 209	parto
#70	AnnotatorNotes T88	C0005615; Birth; Organism Function | C1148523; Childbirth; Organism Function
T89	Form 679 689	comprimido
#71	AnnotatorNotes T89	C0039225; Tablet Dosage Form; Biomedical or Dental Material
T90	PHYS 1877 1882	parto
#72	AnnotatorNotes T90	C0005615; Birth; Organism Function | C1148523; Childbirth; Organism Function
T65	PHYS 1411 1422	tonouterino
T72	Dose 785 792	0,5-0,7
T75	LIVB 363 370	materno
#73	AnnotatorNotes T75	C0026591; Mother (person); Family Group
T13	DISO 350 362	sangramiento
#74	AnnotatorNotes T13	C0019080; Hemorrhage; Pathologic Function
T81	Quantifier_or_Qualifier 575 583	electiva
#76	AnnotatorNotes T81	C1561552; elective; Functional Concept
T82	PHYS 889 913	expulsión de la placenta
T86	Neg_cue 1529 1531	No
T91	CONC 1547 1558	diferencias
#77	AnnotatorNotes T91	C1705241; Delta (difference); Quantitative Concept
T92	LIVB 1801 1808	materno
#78	AnnotatorNotes T92	C0026591; Mother (person); Family Group
A1	Assertion T8 Negated
A2	Population_data T63 Age
R1	Has_Route_or_Mode Arg1:T1 Arg2:T58
R2	Overlap Arg1:T1 Arg2:T59
R3	Location_of Arg1:T3 Arg2:T60
R4	Before Arg1:T1 Arg2:T4
R5	Used_for Arg1:T5 Arg2:T4
R7	Location_of Arg1:T50 Arg2:T9
R8	After Arg1:T9 Arg2:T10
R9	Causes Arg1:T51 Arg2:T9
R10	Negation Arg1:T61 Arg2:T8
R11	Experiences Arg1:T62 Arg2:T8
R12	Experiences Arg1:T63 Arg2:T8
R13	Experiences Arg1:T62 Arg2:T51
R14	Experiences Arg1:T62 Arg2:T10
R15	Experiences Arg1:T62 Arg2:T88
R16	Experiences Arg1:T62 Arg2:T9
R17	Experiences Arg1:T62 Arg2:T7
R18	Overlap Arg1:T12 Arg2:T64
R19	Experiences Arg1:T75 Arg2:T13
R20	Experiences Arg1:T75 Arg2:T66
R21	Location_of Arg1:T14 Arg2:T66
R22	After Arg1:T15 Arg2:T16
R23	Before Arg1:T17 Arg2:T16
R24	Used_for Arg1:T18 Arg2:T17
R28	Before Arg1:T12 Arg2:T15
R29	Experiences Arg1:T75 Arg2:T16
R30	Experiences Arg1:T75 Arg2:T17
R31	Experiences Arg1:T75 Arg2:T15
R32	Experiences Arg1:T67 Arg2:T19
R33	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T81
R34	Has_Dose_or_Strength Arg1:T20 Arg2:T68
R35	Experiences Arg1:T67 Arg2:T20
R36	Has_Route_or_Mode Arg1:T20 Arg2:T69
R37	Experiences Arg1:T67 Arg2:T21
R38	Has_Dose_or_Strength Arg1:T21 Arg2:T70
R39	Has_Drug_Form Arg1:T21 Arg2:T89
R40	After Arg1:T21 Arg2:T23
R41	After Arg1:T20 Arg2:T23
R43	Has_Dose_or_Strength Arg1:T25 Arg2:T72
R44	Combined_with Arg1:T25 Arg2:T26
R45	Used_for Arg1:T25 Arg2:T24
R46	Experiences Arg1:T71 Arg2:T52
R47	Used_for Arg1:T27 Arg2:T52
R48	Has_Dose_or_Strength Arg1:T27 Arg2:T73
R49	After Arg1:T52 Arg2:T82
R50	Experiences Arg1:T71 Arg2:T82
R51	Overlap Arg1:T22 Arg2:T76
R52	Location_of Arg1:T31 Arg2:T74
R53	Experiences Arg1:T77 Arg2:T54
R54	Experiences Arg1:T77 Arg2:T35
R55	Has_Route_or_Mode Arg1:T35 Arg2:T78
R56	Overlap Arg1:T29 Arg2:T79
R57	Experiences Arg1:T77 Arg2:T37
R58	Experiences Arg1:T77 Arg2:T29
R59	Before Arg1:T35 Arg2:T54
R60	Before Arg1:T54 Arg2:T37
R61	Before Arg1:T35 Arg2:T37
R62	Experiences Arg1:T77 Arg2:T38
R63	Experiences Arg1:T77 Arg2:T65
R64	Before Arg1:T54 Arg2:T38
A3	Assertion T91 Negated
R65	Negation Arg1:T86 Arg2:T91
R66	Location_of Arg1:T11 Arg2:T42
R67	Overlap Arg1:T55 Arg2:T83
R68	Used_for Arg1:T56 Arg2:T55
R69	Has_Route_or_Mode Arg1:T56 Arg2:T84
R70	Has_Dose_or_Strength Arg1:T56 Arg2:T85
R72	Location_of Arg1:T45 Arg2:T87
R73	Experiences Arg1:T92 Arg2:T44
R74	Experiences Arg1:T92 Arg2:T87
R75	Experiences Arg1:T92 Arg2:T55
R76	Experiences Arg1:T92 Arg2:T46
R77	Used_for Arg1:T47 Arg2:T46
R78	Experiences Arg1:T92 Arg2:T90
R79	Experiences Arg1:T92 Arg2:T48
R80	Experiences Arg1:T92 Arg2:T57
R81	Before Arg1:T55 Arg2:T48
R82	Before Arg1:T55 Arg2:T46
R84	Experiences Arg1:T75 Arg2:T12	
R6	Before Arg1:T4 Arg2:T6	
R25	Before Arg1:T46 Arg2:T57	
T80	Observation 1 8	Efectos
#75	AnnotatorNotes T80	C1518681; Outcome of Therapy; Finding (?)
R26	Causes Arg1:T1 Arg2:T80	
T93	Observation 306 313	efectos
#79	AnnotatorNotes T93	C1518681; Outcome of Therapy; Finding (?)
R27	Causes Arg1:T12 Arg2:T93	
T94	Observation 1814 1820	efecto
#80	AnnotatorNotes T94	C1518681; Outcome of Therapy; Finding (?)
R42	Causes Arg1:T46 Arg2:T94	
R83	Overlap Arg1:T60 Arg2:T4	
R85	Before Arg1:T2 Arg2:T20	
R86	Before Arg1:T2 Arg2:T21	
A4	Experiencer T67 Patient
A5	Experiencer T71 Patient
A6	Experiencer T77 Patient
A7	Experiencer T92 Patient
A8	Experiencer T62 Patient
A9	Experiencer T63 Patient
A10	Experiencer T75 Patient
